Evidence mapPaperPMID 40439748Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2025

Hybrid attention-based deep learning for multi-label ophthalmic disease detection on fundus images.

Rabiya Hanfi, Harsh Mathur, Ritu Shrivastava

Abstract read
PubMed Publisher
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rabiya HanfiDepartment of Computer Science & Engineering, Rabindranath Tagore University, Bhopal, India. rabiyahanfidr@gmail.com.
Harsh MathurDepartment of Computer Science & Engineering, Rabindranath Tagore University, Bhopal, India.
Ritu ShrivastavaDepartment of Computer Science & Engineering, Sagar Institute of Research and Technology, Bhopal, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOphthalmic diseases significantly impact vision and quality of life. Early diagnosis using fundus images is critical for timely treatment. Traditional deep learning models often lack accuracy, interpretability, and efficiency for multi-label classification tasks in ophthalmology.

methodsWe propose HAM-DNet, a hybrid deep learning model combining EfficientNetV2 and Vision Transformers (ViT) for multi-label ophthalmic disease detection. The model includes SE (Squeeze-and-Excitation) blocks for attention-based feature refinement and a U-Net-based lesion localization module for improved interpretability. The model was trained and tested on multiple fundus image datasets (ODIR-5 K, Messidor, G1020, and Joint Shantou International Eye Centre).

resultsHAM-DNet achieved superior performance with an accuracy of 95.3%, precision of 96.2%, recall of 97.1%, AUC of 98.42, and F1-score of 96.75, while maintaining low computational cost (9.7 GFLOPS). It outperformed existing models including Shallow CNN and EfficientNet, particularly in handling multi-label classifications and reducing false positives and negatives.

conclusionsHAM-DNet offers a robust, accurate, and interpretable solution for automated detection of multiple ophthalmic diseases. Its lightweight architecture makes it suitable for clinical deployment, especially in telemedicine and resource-constrained environments.

Indexed as

Deep LearningEye DiseasesFundus OculiHumansDeep learningEfficientNetV2Fundus imagingLesion localizationOphthalmic disease detectionVision transformers

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.